| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2014↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $26.1B | $23.4B | $20.8B | $20.9B | $19.4B | $16.6B | $5.4B | $5.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.1B | $0.9B | $0.6B | $0.9B | $1.0B | $0.6B | $0.4B | $0.3B |
| Net Income | $0.8B | $0.5B | $0.2B | $0.7B | $1.0B | $0.4B | $0.5B | $0.4B |
| EPS (Basic) | $16.73 | $11.51 | $4.73 | $13.51 | $18.89 | $7.79 | $5.31 | $4.33 |
| EPS (Diluted) | $16.40 | $11.30 | $4.67 | $13.27 | $18.47 | $7.70 | $5.23 | $4.29 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2014↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $17.8B | $16.8B | $16.1B | $15.6B | $15.5B | $14.3B | $13.7B | $5.1B |
| Current Assets | $8.2B | $7.5B | $6.9B | $6.6B | $6.4B | $6.5B | $5.9B | $2.1B |
| Cash & Equivalents | $0.6B | $0.4B | $0.4B | $0.5B | $0.6B | $0.6B | $0.5B | $0.3B |
| Total Liabilities | $10.2B | $9.9B | $9.7B | $9.4B | $9.1B | $8.7B | $8.5B | $2.7B |
| Current Liabilities | $7.4B | $7.1B | $6.4B | $5.9B | $6.5B | $6.1B | $5.5B | $2.0B |
| Stockholders' Equity | $7.5B | $6.8B | $6.3B | $6.0B | $6.2B | $5.5B | $5.1B | $2.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2014↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $0.8B | $0.6B | $0.2B | $1.0B | $1.1B | $0.5B | $0.5B |
| Investing Cash Flow | $-0.3B | $-0.3B | $-0.3B | $-0.2B | $-0.8B | $-0.2B | $-1.0B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | $0.2B |
| Financing Cash Flow | $-0.6B | $-0.5B | $-0.4B | $-0.0B | $-0.1B | $-0.8B | $0.6B | $-0.2B |